Cargando…
Nanoemulsion Adjuvant Augments Retinaldehyde Dehydrogenase Activity in Dendritic Cells via MyD88 Pathway
Mucosal surfaces are the primary point of entry for many infectious agents and mucosal immune responses serve as the primary defense to these pathogens. In order to mount an effective mucosal immune response, it is important to induce T cell homing to mucosal surfaces. Conventional vaccine adjuvants...
Autores principales: | Farazuddin, Mohammad, Goel, Rishi R., Kline, Nicholas J., Landers, Jeffrey J., O'Konek, Jessica J., Baker Jr., James R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517504/ https://www.ncbi.nlm.nih.gov/pubmed/31134057 http://dx.doi.org/10.3389/fimmu.2019.00916 |
Ejemplares similares
-
Mucosal Nanoemulsion Allergy Vaccine Suppresses Alarmin Expression and Induces Bystander Suppression of Reactivity to Multiple Food Allergens
por: Farazuddin, Mohammad, et al.
Publicado: (2021) -
Immunomodulation of T(H)2 biased immunity with mucosal administration of nanoemulsion adjuvant
por: Bielinska, Anna U., et al.
Publicado: (2016) -
The unfulfilled potential of mucosal immunization
por: Baker, James R., et al.
Publicado: (2022) -
Retinoic Acid Signaling Is Required for Dendritic Cell Maturation and the Induction of T Cell Immunity
por: Farazuddin, Mohammad, et al.
Publicado: (2023) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021)